Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2021-12-13 Regulatory Filings
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Episurf Medical’s implants approved for sale in Saudi Arabia
Regulatory Filings Classification · 1% confidence The document announces that Episurf Medical's implants have been approved for sale in Saudi Arabia by the Saudi Food & Drug Authority (SFDA). This is a specific, material event announcement concerning regulatory clearance for a product. It is not a standard periodic report (10-K, IR, ER), a management change (MANG), or a shareholder vote result (DVA). Since it is a specific regulatory/market access announcement that doesn't fit the other specific categories (like M&A, Financing, Dividend), it falls best under the general 'Regulatory Filings' category, which serves as a fallback for miscellaneous regulatory announcements not covered elsewhere. The document length is short, but it is the primary announcement itself, not an announcement *of* another report, making RNS the most appropriate fit among the available options.
2021-12-13 English
Episurf Medical hires Stephen Caswell to head Global Sales OUS
Board/Management Information Classification · 1% confidence The document announces the hiring of a new executive, Stephen Caswell, to head Global Sales OUS. This type of announcement, detailing changes in senior management personnel, directly corresponds to the definition of Board/Management Information. Filing Type Code: MANG (Board/Management Information). The document length is short (3622 chars), but the content is a specific announcement about personnel change, not a general regulatory filing or an announcement of a larger report, thus MANG is the most appropriate classification over RNS or RPA.
2021-12-03 English
Episurf Medical anställer Stephen Caswell som chef för Global Sales OUS
Board/Management Information Classification · 1% confidence The document announces the hiring of a new executive, Stephen Caswell, as Head of Global Sales OUS. It details his background, responsibilities, and includes quotes from him and the CEO regarding this strategic move. This type of announcement, concerning changes in senior management personnel, directly corresponds to the definition of 'Board/Management Information'. The document is a press release format, not a comprehensive financial report (like 10-K or IR) or a general regulatory filing (RNS). Therefore, the appropriate code is MANG.
2021-12-03 Swedish
Major Shareholding Notification 2021
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding percentage for an individual ('Ilija Batljan') following a 'New share issue' ('nyemissionen'). It explicitly states the 'Reason for major shareholding notification' and provides the 'Before' and 'After' distribution of shares and voting rights, culminating in a new total percentage (12.95304%). This structure perfectly matches the definition of a Major Shareholding Notification, which tracks when ownership crosses specific thresholds. The relevant code is MRQ.
2021-12-02 English
Changes in the Nomination Committee for Episurf Medical
Board/Management Information Classification · 1% confidence The document explicitly announces changes to the Nomination Committee ahead of the Annual General Meeting (AGM 2022). It details the members of the Nomination Committee and explains the reason for a specific change (Robert Charpentier now representing Health Runner AB due to a directed issue/shareholder structure change). This content directly relates to the composition and structure of the board/management committees, which falls under Board/Management Information (MANG). It is not a full AGM presentation (AGM-R), a director's dealing report (DIRS), or a general governance report (CGR), but a specific announcement about committee membership.
2021-11-26 English
Förändring i Valberedningen för Episurf Medical
Board/Management Information Classification · 1% confidence The document announces a change in the composition of the Nomination Committee (Valberedningen) for the upcoming Annual General Meeting (AGM) 2022, specifically noting a change in which shareholder representative (Robert Charpentier) will represent a specific shareholder (Health Runner AB) due to a recent directed share issue. This type of announcement concerns the structure and preparation for the AGM, specifically related to board nominations and shareholder representation. This fits best under 'AGM Information' (AGM-R), as it directly relates to the composition of the committee responsible for nominating board members for the AGM. It is not a general management change (MANG), nor is it a voting result (DVA).
2021-11-26 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.